Jula Inrig, Chief Medical Officer: Travere Therapeutics TVTX Sell · Filed 01/07

Trade details

Type: Insider sale
Amount: $81,605.58
Shares · price: 2,031 sh · $40.18 a share
Held after: 86,756 sh
Stock: Travere Therapeutics TVTX
Person: Jula InrigChief Medical Officer
Trade date: 26/01/05
Filed: 26/01/07
Days to filing: 2 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

Jula Inrig's recent trades

Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$2.9M
44,674 sh
$2.9M
Filed 09/15
Traded 09/15
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$900K
20,000 sh
$900K
Filed 05/06
Traded 05/04
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06
Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06

Jula Inrig, Chief Officer — sold $81.6K of Travere Therapeutics TVTX · 2.3% of holdings · 10b5-1 plan | Whalegun